Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04373902

Physiological-based Cord Clamping in Congenital Diaphragmatic Hernia

Physiological-based Cord Clamping Versus Immediate Cord Clamping for Infants Born With Congenital Diaphragmatic Hernia: a Multicentre, Randomised Controlled Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
Erasmus Medical Center · Academic / Other
Sex
All
Age
35 Weeks
Healthy volunteers
Not accepted

Summary

Pulmonary hypertension is a major determinant of postnatal survival in infants with a congenital diaphragmatic hernia (CDH). The current care during the perinatal stabilisation period in infants born with this rare birth defect might contribute to the development of pulmonary hypertension after birth - in particular umbilical cord clamping before lung aeration. An ovine model of diaphragmatic hernia demonstrated that cord clamping after lung aeration, called physiological-based cord clamping (PBCC), avoided the initial high pressures in the lung vasculature while maintaining adequate blood flow, thereby avoiding vascular remodelling and aggravation of pulmonary hypertension. The investigators aim to investigate if the implementation of PBCC in the perinatal stabilisation period of infants born with a CDH could reduce the incidence of pulmonary hypertension in the first 24 hours after birth. The investigators will perform a multicentre, randomised controlled trial in infants with an isolated CDH. Before birth, infants will be randomised to either PBCC or immediate cord clamping, stratified by treatment centre and severity of pulmonary hypoplasia on antenatal ultrasound. For performing PBCC a purpose-designed resuscitation module (the Concord Birth Trolley) will be used.

Conditions

Interventions

TypeNameDescription
PROCEDUREPhysiological-based cord clampingSee 'Arm'

Timeline

Start date
2020-05-11
Primary completion
2026-06-01
Completion
2026-07-01
First posted
2020-05-05
Last updated
2025-09-15

Locations

9 sites across 7 countries: Australia, Austria, Belgium, Germany, Italy, Netherlands, Sweden

Source: ClinicalTrials.gov record NCT04373902. Inclusion in this directory is not an endorsement.